Author: Dr. Amelia Ross
-
AI-Powered Stool Test Detects 90% of Colorectal Cancers — Could Replace Colonoscopies
A groundbreaking study from the University of Geneva has developed an AI-driven stool test that detects colorectal cancer…
-
Scientists Unveil ‘Zombie’ Immune Cells Fueling Aging and Liver Disease
Researchers identify ‘zombie’ immune cells that accelerate aging and fatty liver disease through persistent inflammation, unveiling new treatment…
-
Pfizer Publishes Phase 3 Results for Insulin Efsitora: Weekly Doses Rival Daily Lantus
Pfizer’s insulin efsitora alfa matches daily Lantus in efficacy over 52 weeks, potentially transforming diabetes care with its…
-
WHO Adds Three New Diseases to Neglected Tropical Disease List
The World Health Organization’s recent addition of three diseases to its Neglected Tropical Diseases list marks a significant…
-
Eli Lilly’s New Trial: Foundayo vs Zepbound in 4,800 Adults
Eli Lilly launches a groundbreaking Phase 3 trial comparing its oral GLP-1 pill Foundayo with the injectable Zepbound,…
-
Novo Nordisk Launches Oral Semaglutide vs Wegovy Trial Amid Market Showdown
In a strategic move, Novo Nordisk will conduct a pivotal trial comparing its oral semaglutide against Wegovy, entering…
-
FDA Approves Foundayo as First Oral GLP-1 Pill for Weight Management
In a landmark decision, the FDA has approved Foundayo, the first oral GLP-1 receptor agonist for chronic weight…
-
New Peptide Promises Ozempic’s Appetite Control Without Side Effects
A groundbreaking discovery of a new peptide molecule offers the potential for weight-loss solutions without the adverse effects…
-
Choosing Your Fitness Companion: A Guide to Smart Tracker Features
Fitness trackers blend sensors and coaching to monitor activity, sleep, and health. Learn how to select features like…
-
Navigating Your Wellness Journey: Practical Steps for Lasting Health
Discover actionable strategies to build sustainable fitness habits, from setting realistic goals to finding joy in movement, backed…